439 related articles for article (PubMed ID: 29538751)
1. Heteropolymerization of α-1-antitrypsin mutants in cell models mimicking heterozygosity.
Laffranchi M; Berardelli R; Ronzoni R; Lomas DA; Fra A
Hum Mol Genet; 2018 May; 27(10):1785-1793. PubMed ID: 29538751
[TBL] [Abstract][Full Text] [Related]
2. Intrahepatic heteropolymerization of M and Z alpha-1-antitrypsin.
Laffranchi M; Elliston EL; Miranda E; Perez J; Ronzoni R; Jagger AM; Heyer-Chauhan N; Brantly ML; Fra A; Lomas DA; Irving JA
JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32699193
[TBL] [Abstract][Full Text] [Related]
3. Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization.
Fra AM; Gooptu B; Ferrarotti I; Miranda E; Scabini R; Ronzoni R; Benini F; Corda L; Medicina D; Luisetti M; Schiaffonati L
PLoS One; 2012; 7(6):e38405. PubMed ID: 22723858
[TBL] [Abstract][Full Text] [Related]
4. The pathological Trento variant of alpha-1-antitrypsin (E75V) shows nonclassical behaviour during polymerization.
Miranda E; Ferrarotti I; Berardelli R; Laffranchi M; Cerea M; Gangemi F; Haq I; Ottaviani S; Lomas DA; Irving JA; Fra A
FEBS J; 2017 Jul; 284(13):2110-2126. PubMed ID: 28504839
[TBL] [Abstract][Full Text] [Related]
5. Aberrant disulphide bonding contributes to the ER retention of alpha1-antitrypsin deficiency variants.
Ronzoni R; Berardelli R; Medicina D; Sitia R; Gooptu B; Fra AM
Hum Mol Genet; 2016 Feb; 25(4):642-50. PubMed ID: 26647313
[TBL] [Abstract][Full Text] [Related]
6. Quantitative Lipid Profiling Reveals Major Differences between Liver Organoids with Normal Pi*M and Deficient Pi*Z Variants of Alpha-1-antitrypsin.
Pérez-Luz S; Lalchandani J; Matamala N; Barrero MJ; Gil-Martín S; Saz SR; Varona S; Monzón S; Cuesta I; Justo I; Marcacuzco A; Hierro L; Garfia C; Gomez-Mariano G; Janciauskiene S; Martínez-Delgado B
Int J Mol Sci; 2023 Aug; 24(15):. PubMed ID: 37569847
[TBL] [Abstract][Full Text] [Related]
7. Mineralization of alpha-1-antitrypsin inclusion bodies in Mmalton alpha-1-antitrypsin deficiency.
Callea F; Giovannoni I; Francalanci P; Boldrini R; Faa G; Medicina D; Nobili V; Desmet VJ; Ishak K; Seyama K; Bellacchio E
Orphanet J Rare Dis; 2018 May; 13(1):79. PubMed ID: 29769092
[TBL] [Abstract][Full Text] [Related]
8. Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers.
Schneider CV; Hamesch K; Gross A; Mandorfer M; Moeller LS; Pereira V; Pons M; Kuca P; Reichert MC; Benini F; Burbaum B; Voss J; Gutberlet M; Woditsch V; Lindhauer C; Fromme M; Kümpers J; Bewersdorf L; Schaefer B; Eslam M; Bals R; Janciauskiene S; Carvão J; Neureiter D; Zhou B; Wöran K; Bantel H; Geier A; Dirrichs T; Stickel F; Teumer A; Verbeek J; Nevens F; Govaere O; Krawczyk M; Roskams T; Haybaeck J; Lurje G; Chorostowska-Wynimko J; Genesca J; Reiberger T; Lammert F; Krag A; George J; Anstee QM; Trauner M; Datz C; Gaisa NT; Denk H; Trautwein C; Aigner E; Strnad P;
Gastroenterology; 2020 Aug; 159(2):534-548.e11. PubMed ID: 32376409
[TBL] [Abstract][Full Text] [Related]
9. Alpha-1-antitrypsin (SERPINA1) mutation spectrum: Three novel variants and haplotype characterization of rare deficiency alleles identified in Portugal.
Silva D; Oliveira MJ; Guimarães M; Lima R; Gomes S; Seixas S
Respir Med; 2016 Jul; 116():8-18. PubMed ID: 27296815
[TBL] [Abstract][Full Text] [Related]
10. Alpha-1 Antitrypsin-Deficient Macrophages Have Increased Matriptase-Mediated Proteolytic Activity.
Krotova K; Marek GW; Wang RL; Aslanidi G; Hoffman BE; Khodayari N; Rouhani FN; Brantly ML
Am J Respir Cell Mol Biol; 2017 Aug; 57(2):238-247. PubMed ID: 28362108
[TBL] [Abstract][Full Text] [Related]
11. Application of a diagnostic algorithm for the rare deficient variant Mmalton of alpha-1-antitrypsin deficiency: a new approach.
Belmonte I; Barrecheguren M; López-Martínez RM; Esquinas C; Rodríguez E; Miravitlles M; Rodríguez-Frías F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2535-2541. PubMed ID: 27877030
[TBL] [Abstract][Full Text] [Related]
12. Alpha-1 antitrypsin deficiency: A re-surfacing adult liver disorder.
Fromme M; Schneider CV; Trautwein C; Brunetti-Pierri N; Strnad P
J Hepatol; 2022 Apr; 76(4):946-958. PubMed ID: 34848258
[TBL] [Abstract][Full Text] [Related]
13. Liver disease in alpha-1 antitrypsin deficiency: current understanding and future therapy.
Teckman JH
COPD; 2013 Mar; 10 Suppl 1():35-43. PubMed ID: 23527737
[TBL] [Abstract][Full Text] [Related]
14. Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis.
Mahadeva R; Chang WS; Dafforn TR; Oakley DJ; Foreman RC; Calvin J; Wight DG; Lomas DA
J Clin Invest; 1999 Apr; 103(7):999-1006. PubMed ID: 10194472
[TBL] [Abstract][Full Text] [Related]
15. Amelioration of Alpha-1 Antitrypsin Deficiency Diseases with Genome Editing in Transgenic Mice.
Shen S; Sanchez ME; Blomenkamp K; Corcoran EM; Marco E; Yudkoff CJ; Jiang H; Teckman JH; Bumcrot D; Albright CF
Hum Gene Ther; 2018 Aug; 29(8):861-873. PubMed ID: 29641323
[TBL] [Abstract][Full Text] [Related]
16. The Recruitment-Secretory Block ("R-SB") Phenomenon and Endoplasmic Reticulum Storage Diseases.
Callea F; Tomà P; Bellacchio E
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34202771
[TBL] [Abstract][Full Text] [Related]
17. Liver organoids reproduce alpha-1 antitrypsin deficiency-related liver disease.
Gómez-Mariano G; Matamala N; Martínez S; Justo I; Marcacuzco A; Jimenez C; Monzón S; Cuesta I; Garfia C; Martínez MT; Huch M; Pérez de Castro I; Posada M; Janciauskiene S; Martínez-Delgado B
Hepatol Int; 2020 Jan; 14(1):127-137. PubMed ID: 31832977
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow stem cell therapy partially ameliorates pathological consequences in livers of mice expressing mutant human α1-antitrypsin.
Baligar P; Kochat V; Arindkar SK; Equbal Z; Mukherjee S; Patel S; Nagarajan P; Mohanty S; Teckman JH; Mukhopadhyay A
Hepatology; 2017 Apr; 65(4):1319-1335. PubMed ID: 28056498
[TBL] [Abstract][Full Text] [Related]
19. Is an integrative laboratory algorithm more effective in detecting alpha-1-antitrypsin deficiency in patients with premature chronic obstructive pulmonary disease than AAT concentration based screening approach?
Beletic A; Dudvarski-Ilic A; Milenkovic B; Nagorni-Obradovic L; Ljujic M; Djordjevic V; Mirkovic D; Radojkovic D; Majkic-Singh N
Biochem Med (Zagreb); 2014; 24(2):293-8. PubMed ID: 24969923
[TBL] [Abstract][Full Text] [Related]
20. Alpha(1)-antitrypsin deficiency, liver disease and emphysema.
Parfrey H; Mahadeva R; Lomas DA
Int J Biochem Cell Biol; 2003 Jul; 35(7):1009-14. PubMed ID: 12672469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
